Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peripapillary Vessel Density as Early Biomarker in Multiple Sclerosis.
Cennamo G, Carotenuto A, Montorio D, Petracca M, Moccia M, Melenzane A, Tranfa F, Lamberti A, Spiezia AL, Servillo G, De Angelis M, Petruzzo M, Criscuolo C, Lanzillo R, Brescia Morra V. Cennamo G, et al. Among authors: spiezia al. Front Neurol. 2020 Jun 17;11:542. doi: 10.3389/fneur.2020.00542. eCollection 2020. Front Neurol. 2020. PMID: 32625163 Free PMC article.
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study.
Buonomo AR, Viceconte G, Calabrese M, De Luca G, Tomassini V, Cavalla P, Maniscalco GT, Ferraro D, Nociti V, Radaelli M, Buscarinu MC, Paolicelli D, Gajofatto A, Annovazzi P, Pinardi F, Di Filippo M, Cordioli C, Zappulo E, Scotto R, Gentile I, Spiezia AL, Petruzzo M, De Angelis M, Brescia Morra V, Solaro C, Gasperini C, Cocco E, Moccia M, Lanzillo R; Raising Italian Researchers in Multiple Sclerosis (RIREMS) study group. Buonomo AR, et al. Among authors: spiezia al. J Neurol. 2022 Jun;269(6):3301-3307. doi: 10.1007/s00415-022-11009-x. Epub 2022 Feb 14. J Neurol. 2022. PMID: 35165767 Free PMC article.
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study.
Buonomo AR, Viceconte G, Calabrese M, De Luca G, Tomassini V, Cavalla P, Maniscalco GT, Ferraro D, Nociti V, Radaelli M, Buscarinu MC, Paolicelli D, Gajofatto A, Annovazzi P, Pinardi F, Di Filippo M, Cordioli C, Zappulo E, Scotto R, Gentile I, Spiezia AL, Petruzzo M, De Angelis M, Morra VB, Solaro C, Gasperini C, Cocco E, Moccia M, Lanzillo R; Raising Italian Researchers in Multiple Sclerosis (RIREMS) study group. Buonomo AR, et al. Among authors: spiezia al. J Neurol. 2022 Jun;269(6):3308-3309. doi: 10.1007/s00415-022-11066-2. J Neurol. 2022. PMID: 35377015 Free PMC article. No abstract available.
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study.
Lanzillo R, Carotenuto A, Signoriello E, Iodice R, Miele G, Bisecco A, Maniscalco GT, Sinisi L, Romano F, Di Gregorio M, Lavorgna L, Trojsi F, Moccia M, Fratta M, Capasso N, Dubbioso R, Petracca M, Spiezia AL, Gallo A, Petruzzo M, De Angelis M, Bonavita S, Lus G, Tedeschi G, Brescia Morra V. Lanzillo R, et al. Among authors: spiezia al. J Clin Med. 2022 Apr 7;11(8):2081. doi: 10.3390/jcm11082081. J Clin Med. 2022. PMID: 35456175 Free PMC article.
Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study.
Capasso N, Palladino R, Cerbone V, Spiezia AL, Covelli B, Fiore A, Lanzillo R, Carotenuto A, Petracca M, Stanziola L, Scalia G, Brescia Morra V, Moccia M. Capasso N, et al. Among authors: spiezia al. J Neurol. 2023 Jan;270(1):272-282. doi: 10.1007/s00415-022-11350-1. Epub 2022 Sep 1. J Neurol. 2023. PMID: 36048265 Free PMC article.
Quality of Life Changes in Early-Onset Multiple Sclerosis: A 4-Year Follow-Up Study.
Rosa L, Petracca M, Carotenuto A, Dolce P, Piscopo K, Dicé F, Lauro F, Spiezia AL, Moccia M, Lavorgna L, Iacovazzo C, Servillo G, Maldonato NM, Chiodi A, Brescia Morra V, Lanzillo R. Rosa L, et al. Among authors: spiezia al. J Clin Med. 2022 Sep 4;11(17):5226. doi: 10.3390/jcm11175226. J Clin Med. 2022. PMID: 36079156 Free PMC article.
Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis.
Novarella F, Carotenuto A, Cipullo P, Iodice R, Cassano E, Spiezia AL, Capasso N, Petracca M, Falco F, Iacovazzo C, Servillo G, Lanzillo R, Brescia Morra V, Moccia M. Novarella F, et al. Among authors: spiezia al. Toxins (Basel). 2022 Nov 9;14(11):774. doi: 10.3390/toxins14110774. Toxins (Basel). 2022. PMID: 36356024 Free PMC article.
18 results